Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2016

01-08-2016 | Stanford Multidisciplinary Seminars

Mellow Yellow: Diagnosis and Management of Multifactorial Postoperative Jaundice

Authors: Apurva Tandon, Andrew K. Roorda, Prithvi Legha, Ankur Sangoi, George Triadafilopoulos

Published in: Digestive Diseases and Sciences | Issue 8/2016

Login to get access

Excerpt

A 55-year-old Hispanic man, with a prior history of gastroesophageal reflux disease, fatty liver, and cholelithiasis, was evaluated in the emergency department with complaints of severe right upper quadrant pain that was triggered by food but not associated with any other gastrointestinal symptoms. One month prior, he had been evaluated by his primary care physician due to similar, but less severe and self-limited pain, undergoing an abdominal ultrasound that had revealed cholelithiasis without evidence of cholecystitis. At the time of admission to the hospital, he was afebrile and mildly icteric. His abdominal examination was notable for epigastric tenderness, without rebound or guarding. Laboratory tests were notable for a leukocytosis (17.3 K/μL) and mildly elevated serum liver enzyme concentrations (ALT 69 IU/L; bilirubin 3.2 mg/dL) (Figs. 1, 2). A repeat abdominal ultrasound was reported as showing no evidence of gallbladder wall thickening or acute changes of cholecystitis, but a dilated common bile duct (CBD) at 10.7 mm.
Literature
3.
go back to reference An Y, Xiao YB, Zhong QJ. Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study. World J Gastroenterol. 2006;12:6722.CrossRefPubMedPubMedCentral An Y, Xiao YB, Zhong QJ. Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study. World J Gastroenterol. 2006;12:6722.CrossRefPubMedPubMedCentral
4.
go back to reference Kantrowitz PA, Jones WA, Greenberger NJ, et al. Severe postoperative hyperbilirubinemia simulating obstructive jaundice. N Engl J Med. 1967;276:590.CrossRefPubMed Kantrowitz PA, Jones WA, Greenberger NJ, et al. Severe postoperative hyperbilirubinemia simulating obstructive jaundice. N Engl J Med. 1967;276:590.CrossRefPubMed
5.
go back to reference Seeto RK, Fenn B, Rockey D. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000;109:109–113.CrossRefPubMed Seeto RK, Fenn B, Rockey D. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000;109:109–113.CrossRefPubMed
6.
10.
go back to reference Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis. 2002;22:169–183.CrossRefPubMed Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis. 2002;22:169–183.CrossRefPubMed
11.
go back to reference Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–489.CrossRefPubMed Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–489.CrossRefPubMed
12.
go back to reference Chalasani NP, Hayashi PH, Bonkovsky HL, et al. Diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950–966.CrossRefPubMed Chalasani NP, Hayashi PH, Bonkovsky HL, et al. Diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950–966.CrossRefPubMed
13.
go back to reference Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year Period. Gastroenterology. 2005;129:512–521.CrossRefPubMed Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year Period. Gastroenterology. 2005;129:512–521.CrossRefPubMed
15.
go back to reference Feuer G, Di Fonzo CJ. Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metabol Drug Interact.. 1992;10:1–161.CrossRefPubMed Feuer G, Di Fonzo CJ. Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metabol Drug Interact.. 1992;10:1–161.CrossRefPubMed
16.
go back to reference Machado NO. Biliary complications post laparoscopic cholecystectomy: mechanism, preventive measures, and approach to management: a review. Diagn Ther Endosc. 2011. Machado NO. Biliary complications post laparoscopic cholecystectomy: mechanism, preventive measures, and approach to management: a review. Diagn Ther Endosc. 2011.
17.
go back to reference Barie PS. Acute acalculous cholecystitis. In: Holzheimer RG, Mannick JA, eds. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001. Barie PS. Acute acalculous cholecystitis. In: Holzheimer RG, Mannick JA, eds. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001.
Metadata
Title
Mellow Yellow: Diagnosis and Management of Multifactorial Postoperative Jaundice
Authors
Apurva Tandon
Andrew K. Roorda
Prithvi Legha
Ankur Sangoi
George Triadafilopoulos
Publication date
01-08-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3946-8

Other articles of this Issue 8/2016

Digestive Diseases and Sciences 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.